Biodexa Pharmaceuticals Plc - ADR Live Stock Price Today, Share Analysis and Chart

Name: Biodexa Pharmaceuticals Plc - ADR: Is Infosys Ltd. worth buying?
Item: Biodexa Pharmaceuticals Plc - ADR
Rating: 0.92725
Author: Trendlyne DVM scores

about

Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder ca...

0.86 0.00 (0.00%)

99.81% Fall from 52W High

155.0K

XNAS Volume

XNAS 30 Jul, 2025 1:23 PM (EDT)

Split

Biodexa Pharmaceuticals Plc - ADR has split the face value of its shares from $1 to $10 on 31 Jul 2025. See details

Not Eligible

Expensive Valuation

16.0 / 100

Technically Bearish

21.1 / 100

1Yr Price target upside is 2114%

1 analysts

Biodexa Pharmaceuticals Pl... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..